-
Pharmacology
-
- Enzymes
-
- ATPase & GTPase
- Carboxylase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Hydroxylase
- Isomerase
- Kinase
-
- Adenosine kinase
- Akt
- AMP-kinase
- ATM
- CAM Kinase
- Casein kinase
- Cyclin-dependent kinase
- DNA-dependent Protein Kinase
- DYRK
- General
- Glycogen synthase kinase
- JAK
- MAPK
- mTOR
- Myosin light chain kinase
- PAK
- PI3-kinase
- PLK
- Protein Kinase A
- Protein Kinase C
- Protein Kinase G
- Rho kinase
- Sphingosine kinase
- Src
- Tyrosine Kinase
- Ligase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Orphan 7-TM Receptors
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 2,268 products in: Biochemicals >> Chemical Type
Chemical Type beginning with J - M |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Actin polymerization and stabilization inducer Purity: > 95% |   | ||
| Mitochondrial membrane-potential dye Purity: > 98% | | ||
| Smoothened inhibitor Purity: > 98% |  | ||
| Potent Hedgehog signaling inhibitor Purity: > 99% | | ||
| Selective H4 antagonist Purity: > 99% | | ||
| Potent, selective and reversible fatty acid amide hydrolase inhibitor Purity: > 99% | | ||
| Potent and selective α2C antagonist Purity: > 99% | | ||
| Potent, selective and cell-permeable BET bromodomain inhibitor. Purity: > 98% | | ||
| Potent, selective and irreversible inhibitor of monoacylglycerol lipase (MAGL) Purity: > 98% | | ||
| Highly potent inhibitor of protein and CAM kinases Purity: > 99% | | ||
| Potent, cell-permeable protein kinase C inhibitor and casein kinase II type ectokinase Purity: > 98% | | ||
| Potent, cell-permeable protein kinase C inhibitor Purity: > 98% | | ||
| Potent, highly selective CRF2 antagonist Purity: > 98% | | ||
| Dipeptidyl peptidase 4 (DPP4) inhibitor. Purity: > 98% | | ||
| Phytoestrogen. Proapoptotic agent. Purity: > 98% | | ||
| Prototypic kainate receptor agonist. Purity: > 99% |  | ||
| Aminoglycoside antibiotic Purity: > 98% | | ||
| Promotes differentiation of human mesenchymal stems cells into chondrocytes Purity: > 98% | | ||
| A major component of kava kava extract, has antinociceptive activity. Purity: > 98% | | ||
| NCX inhibitor. TRPC blocker. Purity: > 99% | | ||
| Orally active atypical voltage-gated sodium channel blocker Purity: > 97% | | ||
| Synthetic peptide substrate for PKA Purity: > 95% | | ||
| Potent endothelin receptor antagonist. It is an antiosteoporotic with antibacterial and cytotoxic activity. Purity: > 98% | | ||
| CDK2, GSK3β and LCK inhibitor Purity: > 98% | | ||
| Selective 5-HT2 antagonist. Purity: > 98% | | ||
| Potent cytochrome P450 inhibitor. Anti-fungal agent. Purity: > 99% | | ||
| Oxoeicosanoid (OXE) receptor agonist. Chemoattractant for neutrophils and eosinophils. Purity: > 95% | | ||
| Highly potent COX1/2 inhibitor. Non-steroidal anti-inflammatory drug (NSAID). Purity: > 98% | | ||
| Active metabolite of prostacyclin (PGI2) Purity: > 99% | | ||
| Selective, H1 antagonist Purity: > 99% | | ||
| Highly selective c-Fms tyrosine kinase inhibitor Purity: > 95% | | ||
| AXOR12 agonist Purity: > 95% | | ||
| CaM kinase II inhibitor. P2X7 antagonist. Purity: > 98% | | ||
| Potent, specific CaMK II inhibitor Purity: > 99% | | ||
| Cell-permeable, selective inhibitor of cAMP-dependent protein kinase Purity: > 98% | | ||
| Potent, selective inhibitor of PKG Purity: > 95% | | ||
| Potent, selective, competitive ATM kinase inhibitor Purity: > 99% | | ||
| Endogenous ionotropic / nicotinic antagonist Purity: > 99% | | ||
| Endogenous ionotropic / nicotinic antagonist; water soluble Purity: > 99% | | ||
| An analgesic neuropeptide that inhibits peptide uptake. Purity: > 95% | | ||
| Dopamine ( Purity: > 99% | | ||
| Potent and selective EP4 receptor antagonist Purity: > 98% | | ||
| Voltage dependent L-type calcium channel blocker Purity: > 99% | | ||
| Potent thromboxane A2 receptor antagonist Purity: > 98% | | ||
| Potent and selective γ-secretase inhibitor Purity: > 98% | | ||
| Highly potent 5-HT1D/5-HT1B receptor agonist Purity: > 99% | | ||
| Potent and selective D2 antagonist Purity: > 99% | | ||
| Highly potent, selective brain penetrant D4 antagonist Purity: > 99% | | ||
| Phosphopeptide GSK-3 inhibitor Purity: > 99% | | ||
| Cell-permeable, potent and selective proteasome inhibitor Purity: > 95% | | ||
| Synthetic sugar with various pharmacological effects. Inhibits TNF expression. Purity: > 98% | | ||
| An anti-convulsant drug used to treat seizures, neuropathic pain and epilepsy. Purity: > 98% | | ||
| Somatostatin receptor analog Purity: > 98% | | ||
| Topoisomerase I inhibitor Purity: > 98% | | ||
| Potent ErbB-2 and EGFR dual tyrosine kinase inhibitor. Antitumor. Purity: > 99% | | ||
| Potent, selective tyrosine kinase inhibitor Purity: > 98% | | ||
| Tyrosine kinase inhibitor Purity: > 98% | | ||
| Potent EGF receptor tyrosine kinase inhibitor Purity: > 98% | | ||
| Potent, selective ALK2 and ALK3 inhibitor Purity: > 97% | | ||
| Reversible, competitive UCH-L1 inhibitor Purity: > 98% | | ||
| Pyruvate dehydrogenase kinase (PDK) inhibitor Purity: > 98% | | ||
| Immunomodulatory agent Purity: > 98% | | ||
| Thalidomide analog, TNF-α inhibitor Purity: > 98% | | ||
| Antibiotic, antifungal. Inhibitor of CRM-1 mediated nuclear export. Purity: > 98% | | ||
| Potent JAK2, FLT3 and TrkA receptor tyrosine kinase inhibitor Purity: > 98% | | ||
| Highly potent, reversible, selective aromatase inhibitor Purity: > 99% | | ||
| Calpain inhibitor Purity: > 98% | | ||
| Integrin CD11b/CD19 agonist Purity: > 97% | | ||
| Potent leukotriene A4 hydrolase suicide inhibitor Purity: > 95% | | ||
| Inhibitor of Leukotriene A4 hydrolase Purity: > 99% | | ||
| Potent chemoattractant. Leukotriene B4, BLT1 and BLT2 receptor agonist. Purity: > 99% | | ||
| Arachidonic acid metabolite. Cell-permeable immunomodulator. Purity: > 99% | | ||
| Potent leukotriene C4 receptor agonist Purity: > 98% | | ||
| Potent proinflammatory mediator Purity: > 98% | | ||
| Partial, selective CysLT1 and CysLT2 agonist Purity: > 98% | |